If the first formulation can penetrate below 8000 Hz due to multiple doses, that would have massive implications on the hearing world. If not, treating high frequencies is still a game changer as high and low frequencies would be able to be helped at least in some regard (hearing aids, FX-322, etc.) We know a reformulation will be made to get deeper into the cochlea at some point. The company has expressed their interest in doing so. Right now, they are focused on delivering strong Phase 2a results that warrant Breakthrough Therapy designation from the FDA. If that's granted as I expect it to be, we will be that much closer to reducing the severity of our tinnitus affliction.